Discover 901 paid clinical trials in Birmingham, Alabama. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 901
Aquarius Pilot Study to Evaluate the New Axonics Trial System
for
Urinary Urge Incontinence (UUI), Urinary Frequency (UF),
Location: Birmingham AL, Macon GA, West Columbia SC, Chicago IL
Sponsor: Axonics, Inc.
Sex: All
Age: 18+
Code: NCT07335484
Recruiting
PAS-004 in Adults Who Have Neurofibromatosis Type 1 With Plexiform Neurofibromas
Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Disease
for
Kidney Stones, Kidney Calculi, Urolithiasis,
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 18 - 70+
Code: NCT06989320
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
for
Meningioma
Location: Birmingham AL, New Orleans LA, Jacksonville FL,
Sponsor: Exelixis
Sex: All
Age: 18+
Code: NCT07428616
Phase 2, Recruiting
Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment
for
Small Cell Lung Cancer, Renal Cell Carcinoma (RCC),
Location: Birmingham AL, St Louis MO, Cleveland OH
Sponsor: Advenchen Pharmaceuticals, LLC.
Sex: All
Age: 18+
Code: NCT05363280
Phase 2, Recruiting
Cocoa to Maximize Exercise Training in Older Adults - The COMET Trial
for
Mobility Disability
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 55+
Code: NCT07161726
Phase 1, Phase 2, Recruiting
A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV
Trial of Novel Anti-leukemia Agents in Flu/Mel RIC Transplant for Myeloid Malignancies
for
Myeloid Malignancy, Hematologic Malignancy,
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 18 - 70+
Code: NCT07044544
Phase 1, Recruiting
Retraining and Control Therapy (ReACT) R33 Phase
for
Convulsion, Non-Epileptic
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 11 - 18
Code: NCT06007053
Recruiting
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)